Medtronic Gains FDA Approval For Affera Mapping And Ablation System With Sphere-9 Catheter; First All-In-One HD Mapping And Dual Energy Ablation Device For Treating AFib And Atrial Flutter
Portfolio Pulse from Benzinga Newsdesk
Medtronic has received FDA approval for its Affera Mapping and Ablation System, which includes the Sphere-9 catheter. This is the first all-in-one high-definition mapping and dual energy ablation device designed for treating atrial fibrillation and atrial flutter.
October 24, 2024 | 8:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Medtronic has received FDA approval for its innovative Affera Mapping and Ablation System, which is expected to enhance its product offerings in the treatment of atrial fibrillation and atrial flutter.
The FDA approval of Medtronic's new system is a significant milestone, likely to boost its market position in the cardiac treatment space. This innovation could lead to increased sales and market share, positively impacting the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100